Ji Li

2.2k total citations
122 papers, 1.5k citations indexed

About

Ji Li is a scholar working on Surgery, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Ji Li has authored 122 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Surgery, 31 papers in Oncology and 27 papers in Pathology and Forensic Medicine. Recurrent topics in Ji Li's work include Inflammatory Bowel Disease (15 papers), Genetic factors in colorectal cancer (13 papers) and Microscopic Colitis (10 papers). Ji Li is often cited by papers focused on Inflammatory Bowel Disease (15 papers), Genetic factors in colorectal cancer (13 papers) and Microscopic Colitis (10 papers). Ji Li collaborates with scholars based in China, United States and United Kingdom. Ji Li's co-authors include Jiaming Qian, Dong Wu, Jun Ren, Feng Gao, Heng Ma, Hong Lv, Subrata Ghosh, Jingnan Li, Aito Ueno and Marietta Iacucci and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Ji Li

114 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ji Li China 22 315 300 291 273 258 122 1.5k
Zhirong Zeng China 24 235 0.7× 747 2.5× 277 1.0× 220 0.8× 218 0.8× 70 1.5k
Jan Däbritz Germany 25 307 1.0× 294 1.0× 209 0.7× 282 1.0× 429 1.7× 72 1.5k
C. Graziani Italy 17 283 0.9× 453 1.5× 185 0.6× 267 1.0× 227 0.9× 37 1.4k
Maria DʼArmiento Italy 25 489 1.6× 366 1.2× 180 0.6× 249 0.9× 84 0.3× 83 1.6k
Konstantinos H. Katsanos Greece 22 541 1.7× 271 0.9× 357 1.2× 570 2.1× 228 0.9× 93 2.1k
Yuhki Koike Japan 22 548 1.7× 569 1.9× 226 0.8× 223 0.8× 267 1.0× 97 1.9k
Zenichi Morise Japan 22 491 1.6× 215 0.7× 350 1.2× 260 1.0× 225 0.9× 92 1.5k
Monica V. Talor United States 29 299 0.9× 462 1.5× 325 1.1× 283 1.0× 862 3.3× 77 2.4k
Jarom Heijmans Netherlands 23 405 1.3× 768 2.6× 754 2.6× 300 1.1× 192 0.7× 54 2.6k
Javier Rodríguez‐Carrio Spain 30 216 0.7× 664 2.2× 265 0.9× 236 0.9× 823 3.2× 106 2.4k

Countries citing papers authored by Ji Li

Since Specialization
Citations

This map shows the geographic impact of Ji Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ji Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ji Li more than expected).

Fields of papers citing papers by Ji Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ji Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ji Li. The network helps show where Ji Li may publish in the future.

Co-authorship network of co-authors of Ji Li

This figure shows the co-authorship network connecting the top 25 collaborators of Ji Li. A scholar is included among the top collaborators of Ji Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ji Li. Ji Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Shuang, Hao Tang, Shengyu Zhang, et al.. (2025). Respondence of steroid predicts the long-term clinical and endoscopic prognosis in Cronkhite–Canada syndrome. QJM. 118(8). 567–574.
2.
Li, Muhan, Bei Tan, Shengyu Zhang, et al.. (2025). Comprehensive insights into pathogenesis, diagnosis, treatment, and prognosis in adult autoimmune enteropathy. Orphanet Journal of Rare Diseases. 20(1). 208–208. 1 indexed citations
3.
Huang, Zhicheng, Yadong Wang, Yuan Xu, et al.. (2024). Neoadjuvant BRAF and MEK inhibitor therapy elicits pathological complete response in stage IIIA non‐small cell lung cancer harboring BRAF V600E mutation: A case report. Thoracic Cancer. 15(24). 1825–1828. 1 indexed citations
4.
Yang, Chen, et al.. (2023). Cognition of abdominal pain and abdominal discomfort in Chinese patients with irritable bowel syndrome with diarrhea. BioPsychoSocial Medicine. 17(1). 31–31. 5 indexed citations
5.
Li, Bowen, Ziqi Jia, Zhicheng Huang, et al.. (2023). Adjuvant crizotinib treatment selected by patient-derived organoids in a patient with stage IIIA adenocarcinoma with novel LRRTM4-ALK fusion: a case report. Translational Lung Cancer Research. 12(11). 2322–2329. 2 indexed citations
7.
8.
Zhang, Tianyu, Zhongxun Yu, Yuelun Zhang, et al.. (2023). Clinical phenotypes and prognosis of cytomegalovirus infection in the pediatric systemic lupus erythematosus: a longitudinal analysis. Pediatric Rheumatology. 21(1). 25–25. 4 indexed citations
9.
Xu, Yuan, Dongjie Ma, Yingzhi Qin, et al.. (2023). Is response evaluation criteria in solid tumors (RECIST) effective in patient selection for radical resection after neoadjuvant immunotherapy with advanced NSCLC?. Thoracic Cancer. 14(17). 1635–1639. 5 indexed citations
10.
Zhang, Jinyan, et al.. (2023). Primary rectal mucosa-associated lymphoid tissue lymphoma masquerading as proctitis. Revista Española de Enfermedades Digestivas. 115(12). 744–745.
11.
Yu, Qinyan, Le Chen, Shan Zhang, et al.. (2023). Analyzing the influence of withering degree on the dynamic changes in non-volatile metabolites and sensory quality of Longjing green tea by non-targeted metabolomics. Frontiers in Nutrition. 10. 1104926–1104926. 31 indexed citations
12.
Liu, Shuang, Yan You, Wen You, et al.. (2022). The genomic landscape of Cronkhite–Canada syndrome: Possible clues for pathogenesis. Journal of Digestive Diseases. 23(5-6). 288–294. 3 indexed citations
14.
Li, Ji & Jiaming Qian. (2020). Artificial intelligence in inflammatory bowel disease: current status and opportunities. Chinese Medical Journal. 133(7). 757–759. 11 indexed citations
15.
Li, Ji, et al.. (2019). Reduced RANBP9 expression is associated with poor prognosis in colorectal cancer patients. Translational Cancer Research. 8(8). 2704–2712. 4 indexed citations
16.
Yang, Xinglin, Di Wu, Ji Li, Min Shen, & Wen Zhang. (2018). A Chinese case series of Yao syndrome and literature review. Clinical Rheumatology. 37(12). 3449–3454. 15 indexed citations
17.
Zhang, Shulan, Jing Luo, Ziyan Wu, et al.. (2018). Antibodies against glycoprotein 2 display diagnostic advantages over ASCA in distinguishing CD from intestinal tuberculosis and intestinal Behçet's disease. Clinical and Translational Gastroenterology. 9(2). e133–e133. 18 indexed citations
18.
Li, Ji, Dong Wu, Hong Yang, et al.. (2017). Clinical characteristics of ulcerative colitis‐related colorectal cancer in Chinese patients. Journal of Digestive Diseases. 18(12). 684–690. 18 indexed citations
19.
Du, Shunda, Gang Liu, Xinqi Cheng, et al.. (2016). Differential Diagnosis of Immunoglobulin G4-associated Cholangitis From Cholangiocarcinoma. Journal of Clinical Gastroenterology. 50(6). 501–505. 14 indexed citations
20.
Li, Ji. (2007). Host selection and location behavior of Aprostocetus prolixus LaSalle et Huang (Hymenoptera:Eulophidae), an egg parasitoid of Apriona germari (Hope) (Coleoptera:Cerambycidae). Acta Entomologica Sinica. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026